Mitotic Activity and Nuclear DNA Damage of Large Cells in Hodgkin's Disease: Comparison with the Expression of p53 and bcl-2 Proteins and the Presence of Epstein-Barr Virus

References

• Steel G. G. Growth kinetics of tumours. Cell population kinetics in relation to the growth and treatment of cancer. Clarendon Press, Oxford 1977
   Google Scholar
• Korsmeyer S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879–886
   PubMed Web of Science ®Google Scholar
• Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51: 6304–6311
   PubMed Web of Science ®Google Scholar
• Lane D. P. p53. guardian of the genome. Nature 1992; 358: 15–16
   PubMed Web of Science ®Google Scholar
• Prokocimer M., Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84: 2391–2411
   PubMed Web of Science ®Google Scholar
• Rodrigues N. R., Rowan A., Smith M. E. F., Kerr I. B., Bodmer W. F., Gannon J. V., Lane D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA 1990; 87: 555–7559
   Google Scholar
• Gupta R. K., Norton A. J., Thompson I. W., Lister T. A., Bodmer J. G. p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br. J. Cancer 1992; 66: 649–652
   PubMed Web of Science ®Google Scholar
• Merino R., Ding L., Veis D. J., Korsmeyer S. J., Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 1994; 13: 683–691
   PubMed Web of Science ®Google Scholar
• Doussis I. A., Pezzella F., Lane D. P., Gatter K. C., Mason D. Y. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am. J. Clin. Pathol. 1993; 99: 663–667
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M. T., Spina D., Megha T., Barbini P., Sabattini E., Pileri S., Tosi P., Kraft R., Laissue J. A., Cottier H. Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int. J. Cancer 1995; 61: 826–831
   PubMed Web of Science ®Google Scholar
• Xerri L., Bouabdallah R., Camerlo J., Hassoun J. Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data. Hum. Pathol. 1994; 25: 449–454
   PubMed Web of Science ®Google Scholar
• Chilosi M., Doglioni C., Menestrina F., Montagna L., Rigo A., Lestani M., Barbareschi M., Scarpa A., Mariuzzi G. M., Pizzolo G. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood. 1994; 84: 4295–4300
   PubMed Web of Science ®Google Scholar
• Bhagat S. K. M., Medeiros L. J., Weiss L. M., Wang J., Raffeld M., Stetler-Stevenson M. bcl-2 expression in Hodgkin's disease: correlation with the t(14;18) translocation and Epstein-Barr virus. Am. J. Clin. Pathol. 1993; 99: 604–608
   PubMed Web of Science ®Google Scholar
• Jiwa N. M., Kanavaros P., Van der Valk P., Walboomers J. M., Horstman A., Vos W., Mullink H., Meijer C. J. L. M. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J. Clin. Pathol. 1993; 46: 211–217
   PubMed Web of Science ®Google Scholar
• Lones M. A., Pinkus G. S., Shintaku I. P., Said J. W. bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype. Am. J. Clin. Pathol. 1994; 102: 464–467
   PubMed Web of Science ®Google Scholar
• Ansari B., Coates P. J., Greenstein B. D., Hall P. A. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 1993; 170: 1–8
   PubMed Web of Science ®Google Scholar
• Leoncini L., Spina D., Close P., Bothur P., Megha T., Pacenti L., Tosi P., Pileri S., De Vivo A., Kraft R., Laissue J. A., Cottier H. Abortive mitoses and nuclear DNA fragmentation in CD30+ large cells of Hodgkin's disease. Leuk. Lymphoma 1996; 22: 119–124
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C. B., Falini Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Müller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M. T., Kraft R., Megha T., Barbini P., Cevenini G., Poggi S., Pileri S., Tosi P., Cottier H. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas—A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am. J. Pathol. 1990; 137: 1047–1057
   PubMed Web of Science ®Google Scholar
• Cattoretti G., Pileri S., Parravicini C., Becker M. H., Poggi S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E., Reynolds F., Gerdes J., Rilke F. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol. 1993; 171: 83–98
   PubMed Web of Science ®Google Scholar
• Luzi P., Leoncini L., Funtò I., Bruni A., Lazzi S., Pacenti L., Tosi P. Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas. Virchows. Arch. 1994; 425: 121–125
   PubMed Web of Science ®Google Scholar
• Wilkinson L. SYSTAT: the system for statistics. Systat, Inc, Evanston, IL 1989
   Google Scholar
• Cross R. M. Hodgkin's disease: histological classification and diagnosis. J. Clin. Pathol. 1969; 22: 165–182
   PubMed Web of Science ®Google Scholar
• Del Vecchio M. T., Leoncini L., Buerki K., Kraft R., Megha T., Barbini P., Tosi P., Cottier H. Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int. J. Cancer 1991; 47: 38–43
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M. T., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R., Cottier H. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol. 1993; 142: 755–763
   PubMed Web of Science ®Google Scholar
• Khan G., Coates P. J. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J. Pathol. 1994; 174: 141–149
   PubMed Web of Science ®Google Scholar
• Milner A. E., Johnson G. D., Gregory C. D. Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2 dependent and-independent mechanisms. Int. J. Cancer 1992; 52: 636–644
   PubMed Web of Science ®Google Scholar
• Allen P. D., Bustin S. A., Macey M. G., Johnston D. H., Williams N. S., Newland A. C. Programmed cell death (apoptosis) in immunity and haematological neoplasia. Br. J. Biomed. Sci. 1993; 50: 135–149
   PubMed Web of Science ®Google Scholar
• Vaux D., Cory S., Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–445
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., Thompson C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Imamura J., Miyoshi I., Koeffler H. P. p53 in hematologic malignancies. Blood 1994; 84: 2412–2421
   PubMed Web of Science ®Google Scholar